D&D Pharmatech Inc. (KOSDAQ:347850)
South Korea
· Delayed Price · Currency is KRW 48,150
+2,200 (4.79%)
Apr 1, 2025, 3:30 PM KST
D&D Pharmatech Market Cap
D&D Pharmatech has a market cap or net worth of 485.60 billion as of April 1, 2025.
Market Cap
485.60B
Enterprise Value
464.83B
Revenue
11.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
48,150.00
Market Cap Chart
Since May 2, 2024, D&D Pharmatech's market cap has increased from 379.56B to 485.60B, an increase of 27.94%. That is a compound annual growth rate of 31.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 485.60B | -5.45% |
| Dec 30, 2024 | 513.61B | 35.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 36.29T |
| ALTEOGEN | 18.79T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,776.51B |
| HLB Co., Ltd. | 7,225.34B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,449.36B |